Roche

ROCHE NEWSROOM (43 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

European Medicines Agency accepted Sandoz’s Marketing Authorization Application for biosimilar to Roche’s EU-licensed MabThera®

PRESS RELEASE -- 27, May 2016

Sandoz advances biosimilar portfolio with sixth major biosimilar file acceptance in less than one year Sandoz is seeking approval for all indications included in the reference product’s label Sandoz’ submission includes data from multiple clinical trials with over 800 patients … Read the full press release →

Astaldi led consortium signs EUR 400 million contract for the Dome and of the Main Structure of the European Extremely Large Telescope

PRESS RELEASE -- 26, May 2016

Contract valued at EUR 400 million MUNICH, 26-May-2016 — /EuropaWire/ — The contract signing ceremony was held in Munich today for the design and development of the Dome and of the Main Structure of the E-ELT (European Extremely Large Telescope) to … Read the full press release →

Roche to present 19 approved and investigational medicines at American Society of Clinical Oncology (ASCO) Annual Meeting, 3rd – 7th June in Chicago

PRESS RELEASE -- 6, May 2016

19 Roche medicines are included in more than 200 abstracts during ASCO 2016 New results for cancer immunotherapy atezolizumab in bladder cancer and other cancer types Early results for atezolizumab in combination with targeted medicines and the investigational cancer immunotherapy … Read the full press release →

EU Committee for Medicinal Products for Human Use (CHMP) recommends EU approval of Roche’s Gazyvaro for people with previously treated follicular lymphoma

PRESS RELEASE -- 4, May 2016

In the pivotal study, treatment with Gazyvaro plus bendamustine chemotherapy reduced the risk of disease worsening or death by 52 percent compared to bendamustine alone BASEL, 04-May-2016 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU … Read the full press release →